by ARSACS | Mar 30, 2024 | Research in 2023
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a neurodegenerative disease mainly characterized by cerebellar ataxia, progressive spasticity and peripheral neuropathy. The disease is caused by mutations in the SACS gene (13q11) that alter the...
by ARSACS | Jan 21, 2024 | Research in 2023
The viability of neurons in the brain depends on a complex series of interconnected biochemical reactions that constitute cellular metabolism. Disruption of these metabolic pathways is associated with neurological conditions, including Alzheimer’s and Parkinson’s....
by ARSACS | Oct 9, 2023 | Research in 2023
ARSACS is characterised by the lack of sacsin expression, and the formation of intermediate filaments bundles in neurons and fibroblasts derived from skin biopsies. Our strategy over the last years has been aimed at developing a replacement therapy, by peptide and/or...
by ARSACS | Oct 9, 2023 | Research in 2023
One of the hallmark features of ARSACS is dysfunction and eventual death of Purkinje cells in the cerebellum, which contributes to ataxia. Strikingly, not all Purkinje cells become ill and die: rather, specific patterns of vulnerability and resilience to cell death...
by ARSACS | Oct 9, 2023 | Research in 2023
This project aims to evaluate the contribution of the different cerebellar cell types to neurodegeneration in ARSACS. In our recent publication (Del Bondio et al., 2023) we showed that in the ARSACS mouse cerebellum there is increased expression of astrocytic...
by ARSACS | Oct 9, 2023 | Research in 2023
The Autosomal Recessive Spastic Ataxia of Charlevoix Saguenay (ARSACS) is a rare and depilating neurological disease. It is found with much higher prevalences in several regions of the world, notably in Saguenay Lac St jean. This high prevalence is explained by a...
by ARSACS | Oct 9, 2023 | Research in 2023
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a progressive neurodegenerative genetic disorder characterized by an early childhood onset. ARSACS presents with polyneuropathy, with hallmark loss of cerebellar Purkinje neurons, and movement...
by ARSACS | Oct 9, 2023 | Research in 2023
The cerebellum is critical for the coordination of movements and thought processes. Indeed, patient suffering from spinocerebellar ataxias including ARSACS commonly display psychiatric and cognitive symptoms. These cognitive and neuropsychiatric symptoms are often...
